A study confirms a major concern of cardiologists – after a heart attack lots of patients stop taking or misuse lifesaving cholesterol-lowering drugs known as statins.
Find the truth about questions that pique your curiosity in our series, “The Short Answer.” Preventive cardiologist Haitham Ahmed, MD, MPH, answers this one about cardiovascular disease.
When it comes to patients being observed for small aortic aneurysms, a benefit of statin therapy is not clearly proven. But it’s worth a discussion with your doctor.
Find the truth about questions that pique your curiosity in our series, “The Short Answer.” Preventive cardiologist Haitham Ahmed, MD, MPH, answers this one about supplements and statins.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Newer cholesterol-lowering drugs combined with more conventional medicine reduces bad cholesterol to incredibly low levels, a new study shows. Perhaps even more important, the combination also reduces the heart-attack-inducing plaque that forms inside the arteries.
While many people take statins to protect their heart health, these drugs often are misunderstood — especially when it comes to the safety of these life-saving medicines.
Do you take statin medications to lower “bad” LDL cholesterol? Eating grapefruit while taking these drugs can increase the risk of side effects. This warning has led to a lot of questions from people taking this type of medication. Stanley Hazen, MD, PhD, Preventive Cardiology Head at Cleveland Clinic’s Heart and Vascular Institute, says it’s a … Read More
Could treating depression lower your risk of heart attack or stroke? The results of one study — comparing antidepressants and statins — surprised researchers.
Statin medications (statins) are drugs that help lower cholesterol levels in the blood to help prevent coronary heart disease for those at risk or who already have experienced some form of cardiovascular disease. Statins do carry certain risks that need balanced and managed through ongoing physician monitoring. A recent study highlights how important it is to … Read More
Two new drugs to help physicians better manage “bad” cholesterol (LDL cholesterol) have received approval this week from an FDA advisory panel. The FDA typically accepts those recommendations, so the drugs may soon be available for patient use. The new drugs – both injectables – are called alirocumab (brand name, Praluent), which received the panel’s … Read More